You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Salmeterol Xinafoate

Showing 26 - 50 of 371
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial in Worldwide (FS MDPI, Fp MDPI, Placebo MDPI)

Completed
Has Results
  • Asthma
  • FS MDPI
  • +4 more
  • Birmingham, Alabama
  • +139 more
Nov 11, 2021

Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg inhalation powder/Respirent

Completed
  • Bioequivalence
  • Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg inhalation powder/Respirent Pharmaceuticals
  • +2 more
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Jun 3, 2019

Asthma Trial in Huntington Beach, Raleigh, San Antonio (Fluticasone Propionate MDPI, Fluticasone Propionate/Salmeterol MDPI,

Completed
  • Asthma
  • Fluticasone Propionate MDPI
  • +2 more
  • Huntington Beach, California
  • +2 more
Nov 5, 2021

Bioequivalence Trial in Larissa (Test Product, Reference Product)

Completed
  • Bioequivalence
  • Test Product
  • Reference Product
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Mar 26, 2019

COPD Trial in Antalya (Salmeterol/Fluticasone Capsair®, Salmeterol/Fluticasone Diskus®)

Terminated
  • COPD
  • Salmeterol/Fluticasone Capsair®
  • Salmeterol/Fluticasone Diskus®
  • Antalya, Turkey
  • +1 more
May 16, 2022

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg, ADVAIR DISKUS)

Completed
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg
  • ADVAIR DISKUS
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Dec 27, 2018

Replication of the INSPIRE Trial in Healthcare Claims Data

Completed
  • Chronic Obstructive Pulmonary Disease
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 16, 2021

Asthma Trial in Raleigh, Edmond, San Antonio (Treatment A: Fp MDPI, Treatment B: FS MDPI, Treatment C Flovent)

Completed
  • Asthma
  • Treatment A: Fp MDPI
  • +3 more
  • Raleigh, North Carolina
  • +2 more
Nov 6, 2021

Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)

Completed
Has Results
  • Asthma
  • Mometasone furoate/formoterol (MF/F) MDI
  • Fluticasone propionate/salmeterol (F/SC) DPI
  • (no location specified)
Feb 7, 2022

Asthma Trial (mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID,

Completed
Has Results
  • Asthma
  • mometasone furoate combination MDI 200/10 mcg BID
  • +3 more
  • (no location specified)
Feb 7, 2022

Replication of the POET-COPD Trial in Healthcare Claims Data

Completed
  • Chronic Obstructive Pulmonary Disease
  • Boston, Massachusetts
    Brigham and Women's Hospital
Oct 18, 2021

Asthma Trial in Miami Lakes (Fluticasone Propionate and Salmeterol Inhalation Powder, Placebo Inhalation Powder)

Completed
Has Results
  • Asthma
  • Fluticasone Propionate and Salmeterol Inhalation Powder
  • Placebo Inhalation Powder
  • Miami Lakes, Florida
    Study Site 101
Aug 31, 2021

Asthma Trial (Glycopyrronium bromide 25ug, Placebo, Glycopyrronium bromide 12.5ug)

Recruiting
  • Asthma
  • Glycopyrronium bromide 25ug
  • +2 more
  • Ruse, Bulgaria
  • +11 more
Jan 23, 2023

Asthma Trial in United States (Fluticasone propionate/salmeterol (FS), Albuterol, Standard of Care Asthma Medication)

Completed
  • Asthma
  • Fluticasone propionate/salmeterol (FS)
  • +3 more
  • Phoenix, Arizona
  • +45 more
Jul 15, 2022

Asthma Trial in Worldwide (QVM149 150/50/80 µg o.d., QVM149 150/50/160 µg o.d., salmeterol/fluticasone FDC 50/500 µg b.i.d.)

Completed
Has Results
  • Asthma
  • QVM149 150/50/80 μg o.d.
  • +2 more
  • Sofia, Bulgaria
  • +11 more
Sep 30, 2021

Asthma Trial in Worldwide (Fluticasone Propionate, Fluticasone Propionate/Salmeterol, Placebo MDPI)

Completed
Has Results
  • Asthma
  • Fluticasone Propionate
  • +2 more
  • Birmingham, Alabama
  • +117 more
Nov 5, 2021

Asthma Trial in Denver (fluticasone propionate and salmeterol, budesonide and formoterol)

Completed
  • Asthma
  • fluticasone propionate and salmeterol
  • budesonide and formoterol
  • Denver, Colorado
    National Jewish Health
Jan 15, 2021

Bronchial Asthma Trial in Orlando (Fluticasone propionate/salmeterol 100/50 µg, Placebo, Advair Diskus 100/50 Dry Powder

Completed
  • Bronchial Asthma
  • Fluticasone propionate/salmeterol 100/50 µg
  • +2 more
  • Orlando, Florida
    Combined Research Orlando
Aug 12, 2020

Asthma Trial in Worldwide (QVM149, Salmeterol/fluticasone plus tiotropium)

Completed
Has Results
  • Asthma
  • QVM149
  • Salmeterol/fluticasone plus tiotropium
  • Berazategui, Buenos Aires, Argentina
  • +162 more
Oct 7, 2021

Asthma Trial in Athens (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR

Completed
  • Asthma
  • Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals
  • +2 more
  • Athens, Greece
    BECRO Ltd.
Jul 5, 2020

Asthma Trial in Randwick (Fluticasone Propionate / Salmeterol Xinafoate DISKUS, Fluticasone Propionate / Salmeterol Xinafoate

Completed
  • Asthma
  • Fluticasone Propionate / Salmeterol Xinafoate DISKUS
  • Fluticasone Propionate / Salmeterol Xinafoate ROTACAP
  • Randwick, New South Wales, Australia
    GSK Investigational Site
Jun 18, 2018

(s)of Airflow Limitation in Moderate-severe Persistent Asthma

Recruiting
  • Asthma
  • Lakewood, California
    Arthur F Gelb Medical Corporation
Feb 5, 2021

Asthma in Children Trial in Cincinnati (Cholecalciferol, antihistamine, Azithromycin)

Completed
Has Results
  • Asthma in Children
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jul 28, 2021

Asthma Trial in Guangzhou (Salmeterol Xinafoate and Fluticasone Propinate Powder, Seretide)

Unknown status
  • Asthma
  • Salmeterol Xinafoate and Fluticasone Propinate Powder
  • Seretide
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital Of Guangzhou Medical University
Mar 5, 2018

Asthma Trial in Worldwide (Placebo, Dupilumab SAR231893/REGN668, fluticasone propionate and salmeterol)

Completed
Has Results
  • Asthma
  • Placebo
  • +4 more
  • Tucson, Arizona
  • +15 more
Mar 24, 2022